India produces medicines for an estimated 1.2 billion people and exports to nearly 200 countries, but there are only 1,500 inspectors to ensure quality and safety at 10,000-plus manufacturing facilities in the country, according to officials. One government report found that of 48,082 drug samples collected in 2012, 4.5% were determined to be substandard. Manufacturing plants that make drugs for the U.S. market are subject to inspection by the FDA.

Related Summaries